Related Experiment Videos
Xenogeneic extracellular matrix as a scaffold for tissue reconstruction
1McGowan Institute for Regenerative Medicine, University of Pittsburgh, 100 Technology Drive, Suite 200, Pittsburgh, PA 15219, USA. badylaks@upmc.edu
Transplant Immunology
|May 26, 2004
Summary
Xenogeneic extracellular matrix (ECM) bioscaffolds, derived from decellularized porcine tissues, are safe and effective for tissue repair. These scaffolds promote constructive remodeling over scarring in over 200,000 patients.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Xenogeneic extracellular matrix (ECM) bioscaffolds are utilized in diverse tissue engineering applications.
- Extensive preclinical and clinical studies demonstrate their safety and efficacy in repairing various human tissues.
Purpose of the Study:
- To review the safety and efficacy of xenogeneic ECM bioscaffolds.
- To discuss the biologic response, including immune response, to these materials.
Main Methods:
- Preparation of ECM scaffolds from decellularized porcine organs (e.g., small intestine, urinary bladder).
- Terminal sterilization methods preserving ECM biologic activity.
- Review of preclinical animal and human clinical data.
Main Results:
- Over 200,000 human patients have received xenogeneic ECM scaffold implants.
- Scaffolds retain native mammalian extracellular matrix proteins and three-dimensional organization.
- Demonstrated efficacy in musculoskeletal, cardiovascular, urogenital, and integumentary reconstructions.
Conclusions:
- Xenogeneic ECM bioscaffolds are a proven option for tissue reconstruction.
- Their unique composition promotes constructive tissue remodeling compared to synthetic materials.
- Understanding the biologic and immune response is crucial for their application.